<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"><channel><description>combined internal medicine and psychiatry resident physician</description><link>https://bsky.app/profile/danielpham.bsky.social</link><title>@danielpham.bsky.social - daniel pham</title><item><link>https://bsky.app/profile/danielpham.bsky.social/post/3mcnnzezcgc2i</link><description>Would love to hear from people that did NCSP or GIM Fellowship regarding their experiences.</description><pubDate>17 Jan 2026 22:29 +0000</pubDate><guid isPermaLink="false">at://did:plc:cdysnreanwtdez6zmmevibim/app.bsky.feed.post/3mcnnzezcgc2i</guid></item><item><link>https://bsky.app/profile/danielpham.bsky.social/post/3m6ptmgxzcc2x</link><description>My commentary on skincare (neurocosmetics) and mental health is out! Thanks to @gfriedman.bsky.social for helping out in the process.&#xA;&#xA;[contains quote post or other embedded content]</description><pubDate>28 Nov 2025 21:34 +0000</pubDate><guid isPermaLink="false">at://did:plc:cdysnreanwtdez6zmmevibim/app.bsky.feed.post/3m6ptmgxzcc2x</guid></item><item><link>https://bsky.app/profile/danielpham.bsky.social/post/3lihlfngmbc2c</link><description>My opinion piece in @statnews.com. &#xA;&#xA;I often encounter people with serious mental illness on complex psychotropic regimen simply because they or their prescriber experience regulatory barriers to considering a trial of clozapine. https://www.statnews.com/2025/02/13/clozapine-rems-fda-advisory-panel-neutropenia-treatment-resistant-schizophrenia/ &#xA;&#xA;#FDA #MentalHealth</description><pubDate>18 Feb 2025 15:31 +0000</pubDate><guid isPermaLink="false">at://did:plc:cdysnreanwtdez6zmmevibim/app.bsky.feed.post/3lihlfngmbc2c</guid></item></channel></rss>